Market revenue in 2023 | USD 578.0 million |
Market revenue in 2030 | USD 1,061.5 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 56.87% in 2023. Horizon Databook has segmented the U.S. deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of major competitors & sophisticated healthcare infrastructure and supportive government initiatives are also responsible for market growth in the country. For instance, National Institute of Neurological Disorders and Stroke (NINDS) supports research activities on deep brain stimulation devices as an alternative treatment for PD.
Furthermore, increasing investments for conducting R&D on PD has helped raise awareness and boost development of new & innovative products and therapies for the treatment of this disease. For instance, the National Parkinson Foundation (NPF) provides funds to researchers and scientists with an aim to make advancements in this field.
Extensive research activities for inclusion and approval of deep brain stimulation devices in new application areas, such as depression and full-body MRI scans, are anticipated to boost the market growth over the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account